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Abstract
Dysphagia is defined as an impairment of this complex and integrated sensorimotor system. It is estimated that 400,000 to
800,000 individuals worldwide develop neurogenic dysphagia per year. Neurogenic dysphagia is typically occurring in patients
with neurological disease of different etiologies. A correct and early diagnosis and an appropriate management of dysphagia
could be useful for improving patient’s quality of life and may help to prevent or delay death. In the present review, we discuss
thoroughly the anatomy and physiology of swallowing and also the pathophysiological mechanisms involved in impaired
swallowing, as well as the diagnosis, management, and potential treatments of neurogenic dysphagia. Assessment of neurogenic
dysphagia includes medical history, physical exam, and instrumental examinations (fiberoptic endoscopic evaluation of
swallowing, videofluoroscopic swallowing study, electromyography). Pharmacological treatment of these problems includes
oral anticholinergic drugs. Surgical myotomy of the cricopharyngeal muscle showed an important improvement of oropharyn-
geal dysphagia associated to upper esophageal sphincter hyperactivity. Chemical myotomy of the upper esophageal sphincter by
local injections of botulinum toxin type A into the cricopharyngeal muscle has been proposed as an alternative less invasive and
less unsafe than surgical myotomy.
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Introduction
Swallowing is defined as the semiautomatic motor action
of the muscles of respiratory, oropharyngeal, and
gastrointestinal tract that propels the food from oral cavity
to the stomach and protects airway from food, liquids, and
other substances. During a swallow, different levels of the
central nervous system from the cerebral cortex to the me-
dulla oblongata are involved. About 50 pairs of striated
cranial muscles are excited and/or inhibited sequentially
allowing the bolus transit from the mouth to the stomach.
Dysphagia is defined as an impairment of this complex and
integrated sensorimotor system. Neurogenic dysphagia
(ND) is typically occurring in patients with neurological
disease of different etiologies (see Table 1), and it is asso-
ciated to high mortality, morbidity, and social costs [1–16].
Neurological problems that cause dysphagia can be cate-
gorized in many different ways: anatomic location of the
lesion (e.g., central nervous system, peripheral nervous
system or muscle), pathogenetic mechanism of disease
(e.g., ischemic injury or degenerative process), etiology,
or clinic presentation (e.g., dementia or movement disor-
ders). A correct and early diagnosis and an appropriate
management of dysphagia could be useful for improving
patient’s quality of life and may help to prevent or delay
death. In the present review, we discuss thoroughly the
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pathophysiological mechanisms involved in impaired
swallowing, as well as the diagnosis, management, and
potential treatments of neurogenic dysphagia.
Epidemiology
It is estimated that 400,000 to 800,000 individuals worldwide
develop neurogenic dysphagia per year [17]. The reported
incidence of dysphagia in specific neurologic diseases is var-
iable, owing in part to patient selection methods and evalua-
tion methods (e.g., questionnaires, clinical evaluation, diag-
nostic evaluation). It is generally agreed that stroke is the most
common cause of ND. It is estimated that dysphagia occurs in
approximately 65% of acute stroke patients. In Parkinson’s
disease (PD), dysphagia occurs approximately in 50%.
Dysphagia in multiple sclerosis (MS) occurs in 31.3%.
Dysphagia is common in dementia with prevalence rates vary-
ing from 13 to 57%. Dysphagia is reported to be prevalent in
30–100% of individuals depending on type of motor neuron
disease (MND) and the stage of disease affecting all individ-
uals in the later stages of the disease. There are no data for less
common neurological conditions. Moreover, malnutrition and
aspiration pneumonia are the most common and troublesome
consequences of dysphagia, with increased risk of death in
elderly and debilitated patients. Especially, aspiration pneu-
monia is the most common cause of mortality in patients with
neurological disease associated to dysphagia [18].
Anatomy and physiology of the deglutition
In the forebrain, the most important areas deputed to swallowing
are the anterior insula cortex and the frontoparietal operculum,
including the inferior part of the sensorimotor cortex and a part of
the premotor cortex. The corticobulbar connections originate in
these areas and project to the ipsilateral and contralateral
brainstem nuclei of the main cranial nerves involved in
swallowing. The “central pattern generator” (CPG) for
swallowing is located in the medulla oblongata, corresponding
to the area of the nucleus tractus solitarius (NTS) [19]. CPG
consists of four units, two per side, which receive both ascending
and descending inputs and lead the final stage of the swallow.
The NTS receives afferences from the nucleus ambiguous (NA),
which in turn sends efferent fibers to the most important muscles
for swallowing. Moreover, NTS receives sensitive inputs from
oral, pharyngeal, and laryngeal mucosa as well as from upper
cerebral areas and can modulate swallowing dependent on bolus
properties such as size, texture, and temperature. A lesion which
interrupts these connections thereby produces dysphagia.
Furthermore, the two hemi-CPGs are tightly synchronized and
organize the coordinate contraction of the bilateral muscles of the
oropharyngeal region. Anatomical connections mediated by fi-
bers crossing the midline have been found to exist between the
two CPGs (see Fig. 1).
In ND, disturbances of the oral and/or pharyngeal phase are
very frequent, in contrast to rarely occurring esophageal prob-
lems (oropharyngeal dysphagia). Dysphagia in patients with
brainstem strokes such asWallenberg syndrome ormultiple scle-
rosis is usually caused by a focal lesion which interrupts the
connections between the NTS and the NA ipsilateral to the le-
sion. Within 7–10 days, partial or complete recover occurs spon-
taneously due to vicarious function of the contralateral CPG.
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Tardive dyskinesia and dystonia
The names in italic are the groups of diseases,
but it is easily deductible for the readers
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Instead, the dysphagia in patients with Parkinson’s disease and
parkinsonisms involves pedunculopontine tegmental nucleus
(PPTN) and dorsal motor nucleus of the vagus (DMV). More
rarely, a CPG dysfunction with consequent increase of the inhib-
itory output to PPTN with lack of coordination of swallowing
muscles can occur in PD.Within the esophageal myenteric plex-
us, however, Lewy bodies have been identified.
Peripherally, the swallowing is subdivided into 3 phases:
oral phase, pharyngeal phase, and esophageal phase. The oral
phase is accepted as voluntary, the pharyngeal phase is con-
sidered a reflex response, and the esophageal phase is mainly
under dual control of the somatic and autonomic nervous sys-
tems [20]. The oral phase starts when the food is manipulated
in the month and masticated; its primary function is the move-
ment of the tongue and then the contraction of the lips and
cheek muscles, orbicularis oris muscles, and buccinator mus-
cles. The pharyngeal phase of deglutition involves not only
pharyngeal and laryngeal muscles but also the muscles in the
oral cavity such as tongue and suprahyoid muscles. The
periorbital muscles actively contribute to the involuntary
swallows. The actual motor events of swallowing can best
be described as being composed of two phases: an oropharyn-
geal phase and a subsequent esophageal phase. The duration
of the whole oropharyngeal sequence of swallowing lasts
about 0.6–1.0 s The esophageal phase of swallowing is
slower, may exceed 10 s, and consists of a peristaltic wave
of contraction of the striated and smoothmuscles, which prop-
agates to the stomach.
Diagnosis
Assessment of ND includes medical history, physical exam,
and instrumental examinations.
Clinical swallow evaluation
(1) Note the quality and sound of the patient’s voice: “Wet
voice” may suggest long-term laryngeal aspiration, while a
weak, breathy voice may indicate vocal cord pathology. (2)
Inspection of soft palate and mouth, tongue and lips using a
tongue blade, and handheldmirror allow to detect abnormality
in motor function. (3) Normal laryngeal ascent can be palpated
by placing the index finger above the patient’s thyroid carti-
lage when the patient swallows. The cartilage should move
cephalad against the physician’s finger. (4) Observation of
movements of the patient’s jaw, thereby patient mastication
and patient capacity to mix food and saliva and push the bolus
toward posterior pharynx, without choking or coughing. (5)
Note an excess of saliva in the mouth with consequent stag-
nation. Sialorrhea or hypersalivation is not always due to ex-
cessive production of saliva. In fact, hypersalivation and
drooling are often associated with impairment of swallowing
coordination, and they are known to be associatedwith several
neurological disorders (in Parkinson’s disease, its frequency
varies from 10 to 84%) [21]. (6) Ask the patient to swallow
and note any difficulty doing so. Observing the patient
swallowing a variety of liquids and solids can be helpful to
understand what type of dysphagia it is. Theoretically, dys-
phagia for solids suggests mechanical obstruction caused by
diseases involving the esophagus or the base of the tongue
(e.g., cancer or lymphoma). Dysphagia for liquids suggests a
neurogenic dysphagia. Usually, dysphagia associated with de-
generative diseases starts as dysphagia for liquids, but, over
time, it becomes dysphagia mixed for liquids and solids.
Clinical examination to assess the dysphagia including
“bedside swallowing examination” (BsSE) can be performed
at the bedside by nurses. During “water swallowing test,” the
Fig. 1 The figure shows the
central program generator (CPG)
located in the medulla oblongata
and corresponding to the nucleus
tractus solitaries (NTS), which
receive both ascending and de-
scending inputs and project to the
ipsilateral brainstem nucleus such
as nucleus ambiguous (NA); nu-
cleus of V, VII, IX, X and XII
cranial nerves; and C1–C3 tract of
the cervical medulla. The exis-
tence of two CPGs can explain
the recovery of the swallowing
function after lesion of one CPG
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patient is asked to swallow 50 ml of water in 5-ml aliquots.
ND is diagnosed if the patient chokes or coughs or if any
alteration in the voice quality is detected. If the patient drinks
all 50 ml of water without symptoms, he is considered to
swallow normally. Patients with silent aspiration may have
no problems during this test. Several assessment tools [22]
are used to evaluate and quantify the dysphagia: (1)
Swallowing Disturbance Questionnaire, a self-reported 15-
item questionnaire on swallowing disturbances; (2) Eating
Assessment Tool (EAT-10), a self-administered, symptom-
specific outcome instrument for dysphagia; (3) Dysphagia
Outcome and Severity Scale (DOSS), a 7-point scale devel-
oped to systematically rate the functional severity of dyspha-
gia based on objective assessment; and (4) Penetration-
Aspiration Scale (PAS), an 8-point scale based on VFS, to
describe penetration and aspiration events. This is the most
used scale for semi-quantitatively assessing the degree of en-
doscopically and radiologically measured penetration/
aspiration.
Instrumental assessment
Fiberoptic endoscopic evaluation of swallowing (FEES)
FEES is an assessment using a flexible nasendoscopy, which
is passed into the nares, over the velum and into the pharynx,
in order to perform a functional and morphological study of
the velopharyngeal sphincter and assess pharyngeal and laryn-
geal reflexes. Various aspects of swallowing are observed
directly using colored water and a solid bolus. FEES permits
the detection of abnormalities of swallowing, laryngeal pene-
tration of bolus, or tracheal aspiration. This procedure permits
the evaluation of the efficiency of changes in posture during
rehabilitation in patient with ND [23].
Videofluoroscopic swallowing study (VFSS)
VFSS is a useful tool for determining the presence, severity,
and characteristics of dysphagia [24]. The patient ingests bo-
lus mixed with radiopaque substance, such as barium, using a
range of food and fluid consistencies. The VFS is viewed on a
monitor/screen and recorded allowing a dynamic exploration
of swallowing process from the bolus formation in the oral
cavity to the entrance through the esophageal sphincter to the
stomach. Videofluoroscopy with modified barium swallow
(MBS) is a more commonly used instrumental assessment
for evaluation of swallowing. Studies using MBS testing have
demonstrated subclinical alterations in the oropharyngeal
phase of swallowing in 75–97% of patients with PD.
Pharyngeal manometry complements the MBS with
videofluoroscopy in diagnosing pressure-related causes of
dysphagia. Despite its utility in confirming disorders of the
upper esophageal sphincter (UES) or pharyngeal constriction,
the use of pharyngeal manometry is limited for research pur-
pose due to its complexity. It was postulated that FEES and
VFSS have a sensibility of 80–90% and a specificity of 50%
for detecting aspiration in patients with stroke and other ND.
Electromyography (EMG)
EMG study is very useful in clinical diagnosis to understand
the physiology of activation of muscles involved in oropha-
ryngeal phase of swallowing and also to identify target deglu-
tition muscles for infiltrating with botulinum toxin [25]. There
are several groups ofmuscles of deglutition that can be studied
in detail: (1) jaw and perioral muscles; (2) submandibular/
suprahyoid (SM) muscles; (3) tongue muscles; (4) laryngeal
and pharyngeal muscles; and (5) cricopharyngeal (CP) muscle
of the upper esophageal sphincter (UES). Ertekin and al. [26]
have established a technique for recording the activity of SM
muscles by superficial electrodes and the thyroarytenoid mus-
cle and CP muscle by concentric needle electrode, while the
subject swallows 2–3 ml of water. Furthermore, a piezoelec-
tric accelerometer (transducer) connected to an electromyo-
graph is localized to the thyroid cartilage. This accelerometer
follows hyolaryngeal excursion movements. Surface EMG
activity of the SM muscles gives a considerable amount of
information about the onset and duration of the oropharyngeal
swallowing, because the contraction of the SM muscles pulls
up the hyoid bone into an anterosuperior position, which ele-
vates the larynx and initiates other reflexive changes that con-
stitute the pharyngeal phase of swallowing. When a swallow
is initiated voluntarily, the contraction of the SM muscles
should be controlled by at least two routes. During the initial
part, SM muscles should be activated by the cortical drive
either directly or via the brain stem CPG. The latter part of
SM muscle activation should, however, be controlled by the
CPG of the brain stem network, especially in the period im-
mediately after the onset of laryngeal upward movement,
which is an important and early event of the pharyngeal phase
in voluntarily induced deglutition. When the larynx is pulled
up anterosuperiorly by the SM muscles during the pharyngeal
phase of swallowing, the laryngeal adductor muscles are acti-
vated for the closure of the vocal cords. By this mechanism,
the larynx and lower airways are thought to be protected from
swallowing bolus that is passing through the pharynx. Thus,
the activities of both groups of muscles are interrelated
through the CPG of the swallowing program. Laryngeal ad-
ductor muscles including the thyroarytenoid muscle are main-
ly activated for the protection of the larynx during swallowing.
The protective activity of the laryngeal adductors usually be-
gins after the contraction of the SM muscles in both voluntar-
ily initiated and spontaneous reflex swallows. The CP sphinc-
ter muscle is tonically active during rest, and this continuous
activity ceases during a swallow in human subjects. Usually, it
is preferred simultaneous recording of IC and CP muscle of
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the UES using concentric needle electronic (Fig. 2) and also of
SM and perioral muscles, when it is necessary. The choice of
recording from IC is due to the fact that this is the last pha-
ryngeal muscle temporarily involved in the propulsion of the
bolus toward the esophagus, because it is located in direct
contact with CP. At the activation of IC corresponds a relax-
ation of UES. This period 0,6 msec, the bolus passes from
pharynx to esophagus via UES. IC control is totally voluntary
and represents the input of the reflex relaxation of UES [27].
Management of dysphagia
The main swallowing disturbances are secondary to reduced
lingual control, alterations of movements mostly impaired
tongue base retraction, delayed or absent pharyngeal swallow
reflex, reduced pharyngeal contraction associated to bradyki-
nesia, cricopharyngeal dysfunction, and reduced laryngeal
closure (due to a decreased SM muscles activity). These dis-
orders may be found alone or in association with each other.
Rehabilitation therapy
A rehabilitation treatment plan is decided after evaluation of
patient’s cognitive, motor, and sensory abilities and the impact
of these impaired abilities on the recovery of swallowing func-
tion. Generally, these are patients with stroke, because it is the
most extensively studied neurological condition.
Behavioral intervention such as voluntary airway closure
techniques or other types of swallowing training may be use-
ful in individual cases [28], even if the use of specific maneu-
vers may request help to the caregivers. Anyway, there are no
controlled clinical studies.
Functional therapy is divided into restitution, compensa-
tion, and adaptation methods [29]. (I) Restitution focuses on
partial or complete restitution of disturbed functions. Effortful
swallowing exercise is indicated for patients with an impaired
tongue base retraction and/or reduced pharyngeal propulsion.
Stimulating the anterior faucial pillars effectively triggers the
swallowing reflex. The combination of mechanical, thermal,
and gustatory stimuli seems to be more efficient. (II)
Compensation includes postural changes and swallowing ma-
neuvers. The patient should sit on a chair in a comfortable
way, usually upright position, while eating and drinking. In
patients who have difficulty triggering the swallowing reflex,
tilting the head forward during eatingmay avoid leaking of the
bolus and subsequent aspiration.When tonguemovements are
impaired, resulting in difficulty initiating a swallow, but the
pharyngeal phase of swallowing is intact, tilting the head
backwards helps guide the bolus into the pharynx. The
Mendelsohn maneuver is a technique that helps open the
UES and prolong its opening time. The patient has to hold
the upward movement of the larynx during swallowing for
some seconds. This maneuver is appropriate for patients with
pharyngeal residues or deficient opening of the UES. (III)
Adaptation means modifying the type of food to ease nutri-
tion. Dietary modification may help prevent extremely long
mealtimes, fatigue, and dread of meals. Soft textures or puréed
food can compensate for a poor oral preparation phase and
ease oral and pharyngeal transport. Liquids should be thick-
ened, e.g., with gel water, if thin drinks cause choking.
Triggering the swallowing reflex can be enhanced by empha-
sizing taste or temperature; cooled drinks are often easier to
swallow.
Pharmacological and non-pharmacological therapies
Pharmacological treatment of these problems includes oral
anticholinergic drugs [30].
Fig. 2 The figure shows EMG
recording of the IC (top trace) and
CP (bottom trace) in a health
subject during voluntary
swallowing, using concentric
needle electronic. At the
activation of the IC corresponds a
relaxation of UES allowing that
the bolus passes from the pharynx
to the esophagus. Calibration:
gain, 200 μ V/D; sweep, 500 ms/
D
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Surgical myotomy of the CP, primary muscle of the UES,
showed an important improvement of oropharyngeal dyspha-
gia associated to UES hyperactivity and should be considered
treatment of choice in selected cases with cricopharyngeal
dysfunction [31]. Surgical therapy should have a limited use
because it is performed under general anesthesia and is unsafe
in debilitated patients.
In the last few years, chemical myotomy of UES by local
injections of botulinum toxin type A (BTX-A) into the
cricopharyngeal (CP) muscle of the UES has been proposed
as an alternative, less invasive, and less unsafe than surgical
myotomy. This technique showed to be efficient and without
significant side effects for the treatment of oropharyngeal dys-
phagia associated with different neurological and no neuro-
logical diseases, characterized by hyperactivity or failure/
reduced relaxation of the UES. The advantages of this treat-
ment are safety and repeatability, and it can be still performed
in debilitated patients, because general anesthesia is not nec-
essary. Furthermore, it can be used as a test of efficiency for a
possible following surgical myotomy that may be effective in
about 25% of patients. In fact, it has been established that
patients who respond positively to the chemical myotomy
respond positively to the surgical myotomy [24, 32–34]. The
disadvantages derive from the fact that this technique needs to
be performed by an expert operator and that toxin can spread
to neighboring laryngeal muscles.
As the dysphagia becomes more severe, introduction of
nasogastric tube (NGT) or a percutaneous endoscopic
gastrostomy (PEG) should be considered. NGT is only indi-
cated in patients who have the inability to eat or drink enough,
thereby in persons who are threatened by malnutrition and
dehydration. NGT is indicated for patients with acute diseases
such as stroke or head injury in which the dysphagia may
disappear within weeks or months. In fact NGT can cause
frequent side effects (erosion of mucous, kinking, and shifts
of the tube). PEG is more suitable for patients with degener-
ative diseases [35] such as Parkinson’s disease (PD), parkin-
sonisms, dementia, or amyotrophic lateral sclerosis (ALS) in
which the goal is to feed the patient for a long time (months or
years). The complications with this technique vary fromminor
complications (about 20%) such as local pain or skin infec-
tions to major complications such as peritonitis and pneumo-
nia (about 1–3%).
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